Support Line: 0300 373 8500
This study is testing how safe a new type of targeted treatment is in people with types of lymphoma, including WM.
JNJ-75348780 is a type of drug that targets specific proteins that are known to help cancer cells grow. By stopping these proteins, researchers hope that the cancer cells will stop growing or be killed.
This study is on-going but currently closed to recruitment.
• Confirmed diagnosis of WM
• WM has come back or not responded to treatment
• No further standard treatment options remaining